Back to tenders & grants page
Former Yugoslav Republic of Macedonia-Skopje: Food, beverages, tobacco and related products
Receive Tenders like this by email

Former Yugoslav Republic of Macedonia-Skopje: Food, beverages, tobacco and related products

Former Yugoslav Republic of Macedonia-Skopje: Food, beverages, tobacco and related products has been closed on 18 Feb 2019. It no longer accepts any bids. For further information, you can contact the Sredno medicinsko uciliste na Grad Skopje D-r Pance Karagjozov (1000)

Bellow, you can find more information about this project: 

Location: Macedonia

General information

Donor:

Sredno medicinsko uciliste na Grad Skopje D-r Pance Karagjozov (1000)

Industry:

Beverages

Status:

Closed

Timeline

Published:

02 May 2019

Deadline:

18 Feb 2019

Value:

Not available

Contacts

Name:

PHI General Hospital Kumanovo

Email: [email protected]
[email protected]

Description

Contract notice

Supplies

Legal Basis:

Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses
PHI General Hospital Kumanovo
11 Oktomvri Street, 1300 Kumanovo
Kumanovo
1300
North Macedonia
Contact person: PHI General Hospital Kumanovo
E-mail: [email protected]
NUTS code: MK0

Internet address(es):

Main address: https://www.e-nabavki.gov.mk

Address of the buyer profile: https://www.e-nabavki.gov.mk

I.2)Information about joint procurement
I.3)Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at: www.e-nabavki.gov.mk
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be submitted to the abovementioned address
I.4)Type of the contracting authority
Ministry or any other national or federal authority, including their regional or local subdivisions
I.5)Main activity
Health

Section II: Object

II.1)Scope of the procurement
II.1.1)Title:

Drugs and Medicine (Antibiotics, Fats, Infusion Solutions, Anesthetics, Vaccines, etc.)

II.1.2)Main CPV code
33000000
II.1.3)Type of contract
Supplies
II.1.4)Short description:

According to tender documentation.

II.1.5)Estimated total value
II.1.6)Information about lots
This contract is divided into lots: yes
Tenders may be submitted for all lots
II.2)Description
II.2.1)Title:

D06BA01 Silver Sulfadiazine

Lot No: 1
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

G02AD02 Dinoprostonum

Lot No: 2
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

B05XA03 B05BB01 Sodium Chloride/Electrolytes

Lot No: 3
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

N01BB01 Bupivacain

Lot No: 4
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

B05XA03 B05BB01 Sodium Chloride/Electrolytes

Lot No: 5
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

J06BB02 Tetanus Immunoglobulin

Lot No: 6
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

CO1CA24 Adrenalin

Lot No: 7
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

J06BB05 Rabies Immunoglobulin

Lot No: 8
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

J06BB05 Rabies Immunoglobulin

Lot No: 9
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

S01FA06 Tropicamide

Lot No: 10
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

J07AM01 Tetanus Toxoid 40 IE/0,5 ml Injection Suspension

Lot No: 11
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

B05AA01 Human Albumi/Albumin

Lot No: 12
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

R03AC02 Salbutamol

Lot No: 13
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

N01AF03 Thiopental

Lot No: 14
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

А05BA06 Ornithine

Lot No: 15
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

S01CA01 Dexamethasone, Neomycin, Polymixin B (1 mg/3 500 IE/6 000 IE) 1 ml

Lot No: 16
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

S01BA01 Dexamethasone 1 mg/1 ml

Lot No: 17
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

S01CA01 Tobramycin, Dexamethasone

Lot No: 18
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

S01CA01 Tobramycin, Dexamethasone

Lot No: 19
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

N01BB52 Lidocaine, Epinephrine

Lot No: 20
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

C01CA26 Еphedrine

Lot No: 21
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

M03AC04 Atracurium

Lot No: 22
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

J01FA10 Azithromycin

Lot No: 23
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

N05BA01 Diazepam

Lot No: 24
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

C01CA01 Etilefrine

Lot No: 25
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

N01AH01 Fentanyl

Lot No: 26
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

J01MA03 Pefloxacin

Lot No: 27
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

C04AX Hexobendine, Etofylline, Etamivan

Lot No: 28
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

R03CC05 Hexoprenaline

Lot No: 29
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

N01BB02 Lidocaine

Lot No: 30
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

C02AB02 Methyldopa

Lot No: 31
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

N06BX03 Piracetam

Lot No: 32
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

R03СC02 Salbutamol

Lot No: 33
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

R06AX13 Loratidin

Lot No: 34
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

N02BE01 Paracetamol

Lot No: 35
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

B01AB06 Nadroparin

Lot No: 36
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

B01AB06 Nadroparin

Lot No: 37
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

J01DD01 Cefotaximе

Lot No: 38
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

R06AX13 Loratadine

Lot No: 39
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

H02AB09 Hydrocortisone

Lot No: 40
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

LO3AB11 Pegiinterferon Alfa-2a

Lot No: 41
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

G03DA03 Hydroxyprogesterone

Lot No: 42
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

H04AA01 Glucagon

Lot No: 43
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

A10AB05 Faster Insulin Aspart

Lot No: 44
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

A10AB05 Insulin Aspart

Lot No: 45
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

HO1CB02 Оctreotide

Lot No: 46
II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

According to tender documentation.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information

Section III: Legal, economic, financial and technical information

III.1)Conditions for participation
III.1.1)Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers
III.1.2)Economic and financial standing
III.1.3)Technical and professional ability
III.1.5)Information about reserved contracts
III.2)Conditions related to the contract
III.2.2)Contract performance conditions:
III.2.3)Information about staff responsible for the performance of the contract

Section IV: Procedure

IV.1)Description
IV.1.1)Type of procedure
Open procedure
IV.1.3)Information about a framework agreement or a dynamic purchasing system
IV.1.4)Information about reduction of the number of solutions or tenders during negotiation or dialogue
IV.1.6)Information about electronic auction
IV.1.8)Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: no
IV.2)Administrative information
IV.2.1)Previous publication concerning this procedure
IV.2.2)Time limit for receipt of tenders or requests to participate
Date: 14/02/2019
Local time: 10:00
IV.2.3)Estimated date of dispatch of invitations to tender or to participate to selected candidates
IV.2.4)Languages in which tenders or requests to participate may be submitted:
Macedonian
IV.2.6)Minimum time frame during which the tenderer must maintain the tender
IV.2.7)Conditions for opening of tenders
Date: 20/02/2019
Local time: 10:00

Section VI: Complementary information

VI.1)Information about recurrence
This is a recurrent procurement: no
VI.2)Information about electronic workflows
VI.3)Additional information:
VI.4)Procedures for review
VI.4.1)Review body
State Public Procurement Appeal
Bul. Ilinden 63а, Skopje
Skopje
1000
North Macedonia
E-mail: [email protected]
VI.4.2)Body responsible for mediation procedures
State Public Procurement Appeal
Bul. Ilinden 63а, Skopje
North Macedonia
VI.4.3)Review procedure
VI.4.4)Service from which information about the review procedure may be obtained
State Public Procurement Appeal
Bul. Ilinden 63а, Skopje
North Macedonia
VI.5)Date of dispatch of this notice:
01/02/2019

Featured tenders

Get free access to our Tenders & Grants Database

Our service is free of charge and will always be

Join Now

Donors

Find out more
Request a demo Sign In
Cancel

Enter your contact details

Thank you for requesting a Demo Presentation

One of our experts will be in touch shortly to arrange a convenient time to book a Demo Presentation.

Home page
Cancel

Enter your contact details

Thank you for requesting a Demo Presentation

One of our experts will be in touch shortly to arrange a convenient time to book a Demo Presentation.

Home page